We provide care for children and adults with complex and non complex neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis.
NF1, NF2 and schwannomatosis are inherited conditions that have a major impact on the nervous system and can result in tumour growth.
We are the UK's leading centre for complex NF1, and one of 4 national centres for NF2.
We are an internationally recognised centre for the diagnosis of malignant peripheral nerve sheath tumours in NF1, using PET/CT with glucose (fluorodeoxyglucose).
Our neurofibromatosis specialists work across many areas. See our team page for more information.
Our clinical nurse specialists support patients when they come to clinic and are also available to give advice via telephone and email.
We are committed to the research of neurofibromatosis types 1 and 2, in collaboration with other national and international neurofibromatosis specialists. Current projects include:
improving the diagnosis of malignant peripheral nerve sheath tumours using methionine PET/CT (methionine forms body proteins)
sleep disorders – a significant problem in neurofibromatosis type 1
optic pathway glioma – we are currently evaluating the best way to diagnose and treat this tumour which can eventually lead to blindness in some patients with neurofibromatosis type 1
quality of life in neurofibromatosis – we are assessing the impact of complex inherited diseases on quality of life. This will help to evaluate the effect of new treatments.